Hammerhead ribozymes with cleavage site specificity for NUH and NCH display 
significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and 
CCL13 cells

Gonzalez-Carmona, M. A.; Schussler, S.; Serwe, M.; Alt, M.; Ludwig, J.; Sproat, B. S.; Steigerwald, R.; Hoffmann, P.; Quasdorff, M.; Schildgen, O.; Caselmann, W. H.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells

MPS-Authors

/persons/resource/persons77673

Alt, M.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78744

Steigerwald, R.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gonzalez-Carmona, M. A., Schussler, S., Serwe, M., Alt, M., Ludwig, J., Sproat, B. S., et al. (2006). Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells. Journal of Hepatology, 44(6), 1017-1025.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-62E1-0

Abstract

There is no abstract available